Depression

There is a growing body of evidence suggesting that being exposed to bullying in childhood can contribute to mental health problems later in life. In a new study, published in JAMA Psychiatry, the researchers found that children who reported being bullied at age eight were significantly more likely to seek treatment for mental health problems by age twenty-nine.

“According to a new study, the consequences of this wage gap extend beyond the checking account: women who earn less than their male peers...

According to the CDC, January is National Birth Defects Prevention Month. New research continues to link various SSRI antidepressants with birth defects and neurological abnormalities in newborns. The latest study to examine this topic, a meta-analysis led by Dr. Anick Bérard, found a 23% increased risk for birth defects, and a 28% increased risk for heart problems, in the infants of women who took the SSRI Paxil (paroxetine) during their first trimester.

“Those who possess the data control the story.” In the wake of the reanalysis of the infamous Study 329, where scientific data claiming the antidepressant Paxil was safe and effective for teens was egregiously manipulated, researchers are pushing for open access to raw data. “The issue here, scientists argue, is that without independent confirmation, it becomes too easy to manipulate data.”

Martha Rosenberg calls the reanalysis of Paxil and Study 329 “a victory for safety activists, medical reporters, the public and freedom of the press.” But, she warns, “many pro-pill doctors continue to fight evidence of Paxil’s suicide risks and similar SSRIs.”

On his website, Dr. Nardo details the hidden risks and bad science behind the growing practice of using atypical antipsychotics to augment antidepressant treatment for severe depression. The story of Atypical Antipsychotic Augmentation of Treatment Resistant Depression is a “prime example” “to illustrate how commercial interests have invaded medical practice.” “Besides the obvious dangers of the Metabolic Syndrome and Tardive Dyskinesia, these drugs don’t really do what they’re advertised to do – make the antidepressants work a lot better.”

“The Food and Drug Administration’s approval of pharmaceutical treatment for low sexual desire in women has launched a heated debate over the dangers and benefits of medicalizing sex,” Maya Dusenbery writes in the Pacific Standard. Is “female Viagra” a feminist victory or a product of clever faux-feminist marketing by Big Pharma?

We now have only 89 days to respond to Docket No. FDA-2014-N-1210. Tell the FDA no to the down-classification of shock devices. Tell the FDA exactly how subjective and damaging the terms “treatment-resistant” and “require rapid response” are, and how they fail as legitimate medical concepts. The known risks of electroshock should not be ignored because one has been psychiatrically labeled.

“Suicide rates in the United States have been rising, especially among veterans and members of the armed forces. Traditional assumptions about why people kill themselves have not led to effective strategies for suicide prevention,” psychologist Craig Bryan tells Science News. “So in recent years, psychologists and others have been reconsidering basic beliefs about why people carry out the ultimate act of self-destruction.”

Listen: NPR’s On Point with Tom Ashbrook discusses the new book “Moody Bitches: The Truth About the Drugs You’re Taking, The Sleep You’re Missing, the Sex You’re Not Having and What’s Really Making You Crazy,” by the psychiatrist Julie Holland.

Children of parents who suffer from depression have a severely heightened risk of mental health problems, but new research points to several factors that seem to strengthen young peoples’ resilience and predict good mental health.

Experiencing emotional pain is a necessary part of life. Emotional pain often contains valuable lessons to help us on our journeys. We need to make sure we are not numbing our hearts to those that are hurting. We need to de-stigmatize the struggles, joys and pains that come with being human. We need to not just mindlessly pursue happiness - though we might think of that as an inalienable right - and avoid pain. We need to do the only thing that brings true joy: embrace all of life and each other, as we experience together all that makes us human.

This week another study was published showing that SSRI antidepressant use during pregnancy is associated with increased rates of autism in the children.  By my count, this is now the tenth study on this topic and it follows on the heels of previous studies – all of which found links between SSRI antidepressant use in pregnancy and autism in the offspring.  Most of these studies were recently reviewed by Man, et al, who also concluded that SSRI antidepressant use during pregnancy is associated with autism in the children. So we now have numerous studies in different human populations all showing a link between SSRI use in pregnancy and autism in the children. Yet, much of the news and blogosphere focus on casting doubts about these findings. What is going on here?

Recent meta-analyses of antidepressant clinical trials have revealed that up to 82% of the effects associated with the drugs may be attributed to placebo and non-medication factors. A new study examined the attitudes of psychiatrists toward these non-pharmacologic factors and found a large discrepancy between their beliefs and the empirical evidence.

In Scientific American, Kasley Killam presents insights from research on “post-traumatic growth,” highlighting the importance of finding meaning or underlying significance in our struggles and misery. “The psychiatrist and Holocaust survivor Viktor Frankl wrote extensively about this process after observing that his fellow inmates in concentration camps were more likely to survive the horrific conditions if they held on to a sense of meaning.”

The Daily Telegraph reports on a warning published in the Medical Journal of Australia that urges doctors not to “jump the gun in prescribing patients the drug ketamine to treat depression.”

An analysis of medical records in the UK reveals that the use of certain antidepressants for depression is linked to a heightened risk for mania and bipolar disorder. The research, published this week in BMJ Open, found the strongest effect for serotonin reuptake inhibitors (SSRIs) and the antidepressant venlafaxine.

In a major study, published yesterday in JAMA Pediatrics, the use of SSRI antidepressants during pregnancy was found to increase the risk of autism spectrum disorder (ASD) by 87-percent. Previous studies reveal that more than 13-percent of women currently use SSRI antidepressants during pregnancy.

Psychologist William Copeland writes for Mental Health Recovery that “bullying can occur at any age and the effects of which remain harmful long after the behavior has been endured.” “We, as a society, are just beginning to understand and come to terms with the havoc that bullying wreaks on the emotional lives of its victims.

A new study in JAMA reveals that, on average, 25% of beginning physicians meet the diagnostic criteria for major depression. In an accompanying editorial, Dr. Thomas Schwenk, added: "Everybody asks me, because of some of my prior studies, should we have more intense work in diagnosing depression in students? Of course, the answer is 'yes,' but how do you go about that without further stigmatizing them, further labeling them, further singling them out to even greater stigma? It's not just an issue of, 'Let's make better diagnoses and let's provide better treatment'; it’s more complicated than that."

A phase 1 study for a stem cell derived agent that promotes the growth of new nerve cells in the brain demonstrated efficacy in a very small sample of patients diagnosed with major depressive disorder (MDD). The phase 1B study was published online December 8 in Molecular Psychiatry.

A new study, published this week in BMJ, found no major differences in the effectiveness of cognitive behavioral therapy (CBT) and antidepressants. When the researchers compared previous studies, they found no major differences in relapse rates or level of treatment response between those taking antidepressants and those undergoing CBT.

According to a study published in this month’s British Journal of Psychiatry, people diagnosed with depression in high-income countries are more likely to limit...

Eugene Raikhel reveals ads from 1966 where Ritalin, now prescribed largely for ADHD, was marketed as a “kind of mind antidepressant for housewives.”  “I...

“The National Women’s Health Network launched the 'Pass on the Pink Pill – Or Pass Out' campaign, to warn women of the marginal benefits...